Early impact of CytoSorb® adsorber on proinflammatory cytokine plasmatic levels in a porcine model of refractory cardiogenic shock supported with VA-ECMO
Despite encouraging early benefits, further studies are still necessary to validate interests of a routine use of CytoSorb® adsorber with VA-ECMO.
Authors
- Tristan Ehrlich (ORCID: https://orcid.org/0000-0001-6217-5963)
- Juan‐Pablo Maureira (ORCID: https://orcid.org/0000-0002-3844-5692)
- Fréderique Groubatch-Joineau (ORCID: https://orcid.org/0009-0001-6830-1462)
- Vanessa Marie
- F. R. Ferraro (ORCID: https://orcid.org/0000-0002-2165-8528)
- Aude Falanga (ORCID: https://orcid.org/0009-0006-9605-5445)
- Juliette Piccoli (ORCID: https://orcid.org/0009-0000-8676-173X)
- Fabrice Vanhuyse
- Daniel Grandmougin (ORCID: https://orcid.org/0000-0003-3193-3711)
- Nguyen Tran (ORCID: https://orcid.org/0000-0002-7037-8936)
Institutions
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Université de Lorraine (FR)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1186/s12872-025-05438-5
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00